.png){kind=small}
Bacopa monnieri Extract
50% Bacosides (HPLC) --- BacoWise™ Grade
Botanical Source :
Bacopa monnieri Wettst. aerial parts \| Wetlands of Uttar Pradesh & Bihar, India
Standardisation :
HPLC-verified. BacoWise™ grade represents the highest validated bacosides concentration commercially available.
.png)
Mechanism of Action
Bacopa monnieri\'s active compounds --- bacosides A and B, bacopasides I and II --- modulate neurotransmission, neurogenesis, neuronal plasticity, intracellular signalling, cerebral blood flow, and energy metabolism, with documented anti-apoptotic and antioxidant actions. Three primary mechanisms: (1) ACh / serotonin / GABA modulation --- bacosides enhance acetylcholine synthesis and muscarinic receptor sensitivity; (2) BDNF upregulation and synaptic plasticity support for long-term potentiation (the cellular basis of memory formation); (3) SOD, catalase, and glutathione peroxidase induction in hippocampal and cortical neurons, providing direct neuroprotection.
*Supporting references:* Bacopa 2024 systematic review (PMC11047749)
Top 3 Applications
1. Nutraceuticals / Nootropics --- Memory, Cognition & Brain Health
The landmark 12-week RCT by Calabrese et al. (J Altern Complement Med 2008) in adults 65+ demonstrated significant improvements in delayed-recall scores (AVLT), cognitive performance, and anxiety reduction with 300 mg standardised Bacopa extract. 50% bacosides is the reference grade for all clinical-evidence-based nootropic formulations. \[PMC3153866\]
2. Paediatric & ADHD Support --- Attention & Learning Enhancement Products
StatPearls (2023) identifies Bacopa monnieri as a calming cognitive enhancer with indications for memory improvement, insomnia, and anxiety; it may be used for up to 6 months at 225 mg/day in children aged 6--12. High-purity 50% bacosides supports clean-label paediatric supplement formulation. \[NCBI NBK589635\]
3. Pharma / Neurodegenerative Disease --- Alzheimer\'s Prevention & Cognitive Decline
Bacopa extract demonstrates AChE inhibition and amyloid-β aggregation inhibition in vitro, with multiple studies comparing its activity to donepezil in AD patients. 50% bacosides extract is a compelling natural ingredient for evidence-based longevity and memory-clinic formulations.
Specification & Quality Benchmarks
Solvent system: hydroalcoholic (water/ethanol).
Bacosides (HPLC): ≥ 50% total; Bacoside A ≥ 35%.
Heavy metals: Pb ≤ 1.0 ppm \| Cd ≤ 0.3 ppm \| As ≤ 1.0 ppm \| Hg ≤ 0.1 ppm (ICP-MS).
Pesticide residues: USP \<565\> / EU MRL-compliant.
Microbial: TPC ≤ 10⁴ CFU/g; E. coli & Salmonella absent.
Aflatoxins ≤ 4 ppb.
Shelf life 24 months at ≤ 25 °C in nitrogen-flushed HDPE drums (bacosides are oxidation-sensitive).
Synergy Map — Formulation Pairings
With Ashwagandha root --- flagship Ayurvedic cognitive + adaptogen pairing.
With L-theanine + Magnesium --- calm-focus nootropic stack.
With Lion\'s Mane (Hericium erinaceus) --- dual BDNF/NGF upregulation for premium nootropics.
With Omega-3 DHA --- neuronal-membrane fluidity + synaptic plasticity combination
With Gotu Kola (Centella asiatica) --- classical Ayurvedic medhya pair.
Formulation Intelligence
Typical oral dose: 150--300 mg standardised extract/day (adult); 225 mg/day (paediatric, 6--12 y, clinician-guided).
Formats: capsule, tablet, syrup (paediatric), ghee-based classical preparations, effervescent, gummy.
pH stability: 4.0--7.5.
Solubility: water-dispersible; bacosides partially lipid-soluble --- phytosome delivery enhances bioavailability.
Colour: dark green to brown; flavour earthy-bitter --- blends well with cacao, mint, cardamom.
Buyer's Quick-Qualify
MOQ: 25 kg \| free sample 50 g with TDS, CoA, bacoside HPLC chromatogram.
Lead time: 3--4 weeks ex-works India.
Custom grades: 20%, 40%, 50% bacosides; paediatric-grade (lower-ethanol residue) available.
Organic-certified lot available on advance booking (harvest seasonal).
Export markets served: US, EU, UK, Japan, Australia, GCC.
Market & a Snapshot
Global nootropic ingredient market: \~USD 4 B (2024), CAGR \~12%. Bacopa is a top-3 evidence-backed nootropic botanical globally. Regulatory: US --- DSHEA-compliant; EU --- permitted food supplement (botanical monograph in progress); Health Canada NHP-licensed; Australia TGA-listed; India --- AYUSH-classical Medhya Rasayana.
Emerging Applications
Bacopa gummies and paediatric syrups scaling rapidly. Phytosome-delivered Bacopa (10× absorption) emerging as a premium format for memory-clinic and longevity applications. Research frontier: amyloid-β aggregation inhibition, BDNF upregulation in post-stroke recovery, and post-COVID cognitive-fog trials.
Key Scientific References
-
Calabrese C et al. J Altern Complement Med. 2008;14:707--713
-
Bacopa 2024 systematic review Antioxidants (PMC11047749)
-
StatPearls Bacopa monnieri (NBK589635)
Contact & Next Steps
PHELBA Life Sciences · Technical Data Sheets, Certificates of Analysis, HPLC
chromatograms, stability studies, and 50–100 g free samples are available on
request for any SKU.
Website
Markets Served
US, EU, UK, Japan, Australia, GCC, ASEAN
All extracts manufactured at our cGMP- and ISO 9001:2015-certified partner facilities in India.
FSSAI- and HACCP-licensed. Halal and Kosher certification available on request. Organic (NPOP / NOP / EU-Organic) variants available on select SKUs.